Lactulose Sandoz

Lactulose, the active ingredient in Lactulose Sandoz, is an osmotic laxative presented as an oral formulation for oral use. It treats constipation and helps manage hepatic encephalopathy in patients with liver disease.

GNH USA supplies Lactulose Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lactulose is used as an osmotic laxative and as a therapy for hepatic encephalopathy.

- Constipation: Softens stool and promotes bowel movements in patients with functional constipation. - Hepatic encephalopathy: Reduces intestinal ammonia absorption, helping to lower blood ammonia levels in patients with liver disease.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Flatulence: Excess gas production leading to bloating. - Abdominal cramping: Mild to moderate stomach cramps. - Diarrhea: Loose stools, especially at higher doses. - Nausea: Feeling of sickness. - Electrolyte imbalance: Minor changes in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: Marked fluid loss requiring medical attention. - Hypokalemia: Low potassium levels that may cause cardiac issues. - Allergic reaction: Rash, itching, swelling, or difficulty breathing. - Hypernatremia: Elevated sodium levels in rare cases.

Before initiating lactulose therapy, consider the following precautions.

- Renal impairment: Use with caution in patients with reduced kidney function. - Diabetes mellitus: Monitor blood glucose as lactulose may affect glucose control. - Electrolyte monitoring: Check serum electrolytes during prolonged therapy. - Pediatric use: Dose adjustment may be required for children. - Pregnancy and lactation: Safety not established; weigh benefits against potential risks. - Store at ambient temperature: Keep below 25°C, in original container, protect from moisture.

Lactulose can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Antibiotics (e.g., rifaximin): May reduce lactulose efficacy by altering gut flora. - Laxatives (e.g., bisacodyl): Combined use can cause severe diarrhea and electrolyte loss. - Mineral supplements (e.g., magnesium): May increase risk of diarrhea.

Moderate Interactions (Monitor Closely): - Diuretics: Potential additive effect on electrolyte balance. - Insulin or oral hypoglycemics: Lactulose can affect glucose absorption, requiring dose adjustment. - Proton pump inhibitors: May alter gastric pH, influencing lactulose activity.